Literature DB >> 26424630

Can epicardial adipose tissue predict coronary artery plaque?

Ömer Hinç Yılmaz1, Uğur Nadir Karakulak, Engin Tutkun, Emine Ercan Onay.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26424630      PMCID: PMC5368498          DOI: 10.5152/AnatolJCardiol.2015.6525

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, We read with great interest the manuscript written by Çullu et al. (1) titled “Does epicardial adipose tissue volume provide information about the presence and localization of coronary artery disease?” published in the May 2015 issue of Anatol J Cardiol 2015; 15: 355-9. In that study, authors investigated the relationship between the epicardial adipose tissue (EAT) volume and the atherosclerotic coronary artery plaques evaluated by computed tomography (CT). In this study, EAT volumes were found to be significantly higher in patients with coronary plaques than in patients without plaques. Furthermore, the left anterior descending (LAD) artery and multivessel located coronary atheromatous plaques were associated with higher EAT volumes than other coronary artery locations as well as with the absence of coronary plaques. One of the most important finding in this study is that the frequency of diabetes mellitus (DM), hypertension (HT), and dyslipidemia were found to be significantly higher not only in cases with plaque but also in cases with increased EAT volume. Similar results were shown in studies that evaluated the relation-ship between EAT and DM, HT, and hyperlipidemia (2-4). However, it is not clear whether EAT volume could predict the presence of plaque in coronary arteries in the current study (1). Both EAT volumes and risk factors for atherosclerosis, including DM, HT, hyperlipidemia, and age, are higher in patients with coronary plaque. Thus, in that case, multivariate regression analysis should be made to adjust for the confusing effects of these risk factors. It is impossible to say that “EAT volumes predict the presence of coronary plaque and plaque-involved vessels.” If the EAT volume is found as an independent predictor for coronary plaque after regression analysis, the ROC analysis can be used to determine the cut-off value. Otherwise, it would be more appropriate to say that EAT volume is a “risk factor” for coronary plaque. Finally, coronary artery calcium (CAC) scores were written as mean±standard deviation, such as 53.4±138 and 80±163, in Table 1. We think that CAC score does not show the normal distribution; therefore, it should be represented as median with minimum and maximum range.
  4 in total

1.  The relationship between coronary artery disease and pericoronary epicardial adipose tissue thickness.

Authors:  Ayşe Murat Aydın; Alperen Kayalı; Ahmet Kurşad Poyraz; Kemal Aydın
Journal:  J Int Med Res       Date:  2014-12-04       Impact factor: 1.671

2.  Epicardial adipose tissue and insulin resistance in patients with coronary artery disease with or without left ventricular dysfunction.

Authors:  Samuele Baldasseroni; Alessandra Pratesi; Francesco Orso; Claudia Di Serio; Alice Foschini; Andrea Giosafat Marella; Nadia Bartoli; Mauro Di Bari; Stefano Fumagalli; Niccolò Marchionni; Francesca Tarantini
Journal:  Monaldi Arch Chest Dis       Date:  2013-12

3.  Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning).

Authors:  Nikolaos Alexopoulos; Bekir H Melek; Chesnal D Arepalli; Gregory-Randell Hartlage; Zhengjia Chen; Sungjin Kim; Arthur E Stillman; Paolo Raggi
Journal:  J Am Coll Cardiol       Date:  2013-03-14       Impact factor: 24.094

4.  Does epicardial adipose tissue volume provide information about the presence and localization of coronary artery disease?

Authors:  Neşat Çullu; Mecit Kantarcı; Yeşim Kızrak; Berhan Pirimoğlu; Ümmügülsüm Bayraktutan; Hayri Oğul; Leyla Karaca
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.